Regenerative Medicine Market to 2027 - Global Analysis and Forecasts by Type ( Cell-Based Immunotherapy and Cell Therapy Products, Tissue-Engineered Products, Gene Therapy Products ); Application ( Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes )
Report Code: TIPHE100001194 No. of Pages: 150 Category: Biotechnology Status: Upcoming
MARKET INTRODUCTION
Regenerative medicine is an interdisciplinary field of medicine that is used for developing methods to grow, repair or replace diseased or damaged cells, tissues, and organs. Regenerative medicine involves the generation and use of therapeutic stem cells, tissue engineering and the production of artificial organs. Major focus in the regenerative medicine fields are cellular therapies, tissue engineering & biomaterials, and medical devices and artificial organs. Along with replacement of damaged organs, regenerative medicine also helps with the regeneration of the organs.
MARKET DYNAMICS
Regenerative medicine market is anticipated to grow in the forecast period owing to driving factors such as Considerable rise in the number of individuals opting for organ transplant. Increase in the global healthcare expenditure coupled with rising prevalence of genetic and chronic diseases is expected to fuel the market growth in the coming years.
MARKET SCOPE
The "Global Regenerative Medicine Market Analysis to 2027" is a specialized and in-depth study of the regenerative medicine industry with a special focus on the global market trend analysis. The report aims to provide an overview of regenerative medicine market with detailed market segmentation by type, application and geography. The global regenerative medicine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading regenerative medicine market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global regenerative medicine market is segmented on the basis of type, application. Based on type, the market is segmented cell-based immunotherapy and cell therapy products, tissue-engineered products and gene therapy products. On the basis of application, the global regenerative medicine market is segmented in to musculoskeletal disorders, wound care, oncology, ocular disorders and diabetes.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global regenerative medicine market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The regenerative medicine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting regenerative medicine market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the regenerative medicine market in these regions.
MARKET PLAYERS
The reports cover key developments in the regenerative medicine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from regenerative medicine market are anticipated to lucrative growth opportunities in the future with the rising demand for regenerative medicine in the global market. Below mentioned is the list of few companies engaged in the regenerative medicine market.
The report also includes the profiles of key regenerative medicine market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Integra LifeSciences Corporation
- Gilead Sciences
- Novartis
- Vericel Corporation
- Wright Medical
- MiMedx
- Osiris Therapeutics
- Stryker Corporation
- Spark Therapeutics
- Medtronic
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Regenerative Medicine Market - By Type
1.3.2 Regenerative Medicine Market - By Application
1.3.3 Regenerative Medicine Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. REGENERATIVE MEDICINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. REGENERATIVE MEDICINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. REGENERATIVE MEDICINE MARKET - GLOBAL MARKET ANALYSIS
6.1. REGENERATIVE MEDICINE - GLOBAL MARKET OVERVIEW
6.2. REGENERATIVE MEDICINE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. REGENERATIVE MEDICINE MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. CELL-BASED IMMUNOTHERAPY AND CELL THERAPY PRODUCTS
7.3.1. Overview
7.3.2. Cell-Based Immunotherapy and Cell Therapy Products Market Forecast and Analysis
7.3.3. Allogeneic Products Market
7.3.3.1. Overview
7.3.3.2. Allogeneic Products Market Forecast and Analysis
7.3.4. Autologous Products Market
7.3.4.1. Overview
7.3.4.2. Autologous Products Market Forecast and Analysis
7.4. TISSUE-ENGINEERED PRODUCTS
7.4.1. Overview
7.4.2. Tissue-Engineered Products Market Forecast and Analysis
7.5. GENE THERAPY PRODUCTS
7.5.1. Overview
7.5.2. Gene Therapy Products Market Forecast and Analysis
8. REGENERATIVE MEDICINE MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. MUSCULOSKELETAL DISORDERS
8.3.1. Overview
8.3.2. Musculoskeletal Disorders Market Forecast and Analysis
8.4. WOUND CARE
8.4.1. Overview
8.4.2. Wound Care Market Forecast and Analysis
8.5. ONCOLOGY
8.5.1. Overview
8.5.2. Oncology Market Forecast and Analysis
8.6. OCULAR DISORDERS
8.6.1. Overview
8.6.2. Ocular Disorders Market Forecast and Analysis
8.7. DIABETES
8.7.1. Overview
8.7.2. Diabetes Market Forecast and Analysis
9. REGENERATIVE MEDICINE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Regenerative Medicine Market Overview
9.1.2 North America Regenerative Medicine Market Forecasts and Analysis
9.1.3 North America Regenerative Medicine Market Forecasts and Analysis - By Type
9.1.4 North America Regenerative Medicine Market Forecasts and Analysis - By Application
9.1.5 North America Regenerative Medicine Market Forecasts and Analysis - By Countries
9.1.5.1 United States Regenerative Medicine Market
9.1.5.1.1 United States Regenerative Medicine Market by Type
9.1.5.1.2 United States Regenerative Medicine Market by Application
9.1.5.2 Canada Regenerative Medicine Market
9.1.5.2.1 Canada Regenerative Medicine Market by Type
9.1.5.2.2 Canada Regenerative Medicine Market by Application
9.1.5.3 Mexico Regenerative Medicine Market
9.1.5.3.1 Mexico Regenerative Medicine Market by Type
9.1.5.3.2 Mexico Regenerative Medicine Market by Application
9.2. EUROPE
9.2.1 Europe Regenerative Medicine Market Overview
9.2.2 Europe Regenerative Medicine Market Forecasts and Analysis
9.2.3 Europe Regenerative Medicine Market Forecasts and Analysis - By Type
9.2.4 Europe Regenerative Medicine Market Forecasts and Analysis - By Application
9.2.5 Europe Regenerative Medicine Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Regenerative Medicine Market
9.2.5.1.1 Germany Regenerative Medicine Market by Type
9.2.5.1.2 Germany Regenerative Medicine Market by Application
9.2.5.2 France Regenerative Medicine Market
9.2.5.2.1 France Regenerative Medicine Market by Type
9.2.5.2.2 France Regenerative Medicine Market by Application
9.2.5.3 Italy Regenerative Medicine Market
9.2.5.3.1 Italy Regenerative Medicine Market by Type
9.2.5.3.2 Italy Regenerative Medicine Market by Application
9.2.5.4 Spain Regenerative Medicine Market
9.2.5.4.1 Spain Regenerative Medicine Market by Type
9.2.5.4.2 Spain Regenerative Medicine Market by Application
9.2.5.5 United Kingdom Regenerative Medicine Market
9.2.5.5.1 United Kingdom Regenerative Medicine Market by Type
9.2.5.5.2 United Kingdom Regenerative Medicine Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Regenerative Medicine Market Overview
9.3.2 Asia-Pacific Regenerative Medicine Market Forecasts and Analysis
9.3.3 Asia-Pacific Regenerative Medicine Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Regenerative Medicine Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Regenerative Medicine Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Regenerative Medicine Market
9.3.5.1.1 Australia Regenerative Medicine Market by Type
9.3.5.1.2 Australia Regenerative Medicine Market by Application
9.3.5.2 China Regenerative Medicine Market
9.3.5.2.1 China Regenerative Medicine Market by Type
9.3.5.2.2 China Regenerative Medicine Market by Application
9.3.5.3 India Regenerative Medicine Market
9.3.5.3.1 India Regenerative Medicine Market by Type
9.3.5.3.2 India Regenerative Medicine Market by Application
9.3.5.4 Japan Regenerative Medicine Market
9.3.5.4.1 Japan Regenerative Medicine Market by Type
9.3.5.4.2 Japan Regenerative Medicine Market by Application
9.3.5.5 South Korea Regenerative Medicine Market
9.3.5.5.1 South Korea Regenerative Medicine Market by Type
9.3.5.5.2 South Korea Regenerative Medicine Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Regenerative Medicine Market Overview
9.4.2 Middle East and Africa Regenerative Medicine Market Forecasts and Analysis
9.4.3 Middle East and Africa Regenerative Medicine Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Regenerative Medicine Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Regenerative Medicine Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Regenerative Medicine Market
9.4.5.1.1 South Africa Regenerative Medicine Market by Type
9.4.5.1.2 South Africa Regenerative Medicine Market by Application
9.4.5.2 Saudi Arabia Regenerative Medicine Market
9.4.5.2.1 Saudi Arabia Regenerative Medicine Market by Type
9.4.5.2.2 Saudi Arabia Regenerative Medicine Market by Application
9.4.5.3 U.A.E Regenerative Medicine Market
9.4.5.3.1 U.A.E Regenerative Medicine Market by Type
9.4.5.3.2 U.A.E Regenerative Medicine Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Regenerative Medicine Market Overview
9.5.2 South and Central America Regenerative Medicine Market Forecasts and Analysis
9.5.3 South and Central America Regenerative Medicine Market Forecasts and Analysis - By Type
9.5.4 South and Central America Regenerative Medicine Market Forecasts and Analysis - By Application
9.5.5 South and Central America Regenerative Medicine Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Regenerative Medicine Market
9.5.5.1.1 Brazil Regenerative Medicine Market by Type
9.5.5.1.2 Brazil Regenerative Medicine Market by Application
9.5.5.2 Argentina Regenerative Medicine Market
9.5.5.2.1 Argentina Regenerative Medicine Market by Type
9.5.5.2.2 Argentina Regenerative Medicine Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. REGENERATIVE MEDICINE MARKET, KEY COMPANY PROFILES
11.1. INTEGRA LIFESCIENCES CORPORATION
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. GILEAD SCIENCES
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. NOVARTIS
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. VERICEL CORPORATION
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. WRIGHT MEDICAL
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. MIMEDX
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. OSIRIS THERAPEUTICS
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. STRYKER CORPORATION
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SPARK THERAPEUTICS
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. MEDTRONIC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies
1. Integra LifeSciences Corporation
2. Gilead Sciences
3. Novartis
4. Vericel Corporation
5. Wright Medical
6. MiMedx
7. Osiris Therapeutics
8. Stryker Corporation
9. Spark Therapeutics
10. Medtronic